| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9370383 | Archives de Pédiatrie | 2005 | 4 Pages |
Abstract
Conclusion. - This study confirms the relative benignity of SSRI exposure during the late pregnancy. Our recommendations for monitoring the newborns during their stay in maternity were well respected. The risk of hemorrhagic symptoms or hyponatremia, not well known by pediatricians, deserves to be recalled to medical teams who take in charge newborns exposed to SSRI.
Related Topics
Health Sciences
Medicine and Dentistry
Perinatology, Pediatrics and Child Health
Authors
H. Cissoko, D. Swortfiguer, B. Giraudeau, A.-P. Jonville-Béra, E. Autret-Leca,